1
|
Alai J, Callen EF, Clay T, Goodman DW, Adler LA, Faraone SV. Differences in Primary Care Management of Patients With Adult Attention Deficit Hyperactivity Disorder (ADHD) Based on Race and Ethnicity. J Atten Disord 2024; 28:923-935. [PMID: 38214134 DOI: 10.1177/10870547231218038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/13/2024]
Abstract
OBJECTIVE Examine differences in care patterns around adult ADHD between race (White/Non-White) and ethnic (Hispanic/Non-Hispanic) groups utilizing existing quality measures (QMs), concerning diagnosis, treatment, and medication prescribing. METHODS The AAFP National Research Network in partnership with SUNY Upstate Medical used an EHR dataset to evaluate achievement of 10 ADHD QMs. The dataset was obtained from DARTNet Institute and includes 4 million patients of 873 behavioral and primary care practices with at least 100 patients from 2010 to 2020. Patients 18-years or older with adult ADHD were included in this analysis. RESULTS White patients and Non-Hispanic/Latinx patients were more likely to achieve these QMs than Non-White patients and Hispanic/Latinx patients, respectively. Differences between groups concerning medication and monitoring demonstrate a disparity for Non-White and Hispanic/Latinx populations. CONCLUSIONS Using QMs in EHR data can help identify gaps in ADHD research. There is a need to continue investigating disparities of quality adult ADHD care.
Collapse
Affiliation(s)
- Jillian Alai
- American Academy of Family Physicians, Leawood, KS, USA
- DARTNet Institute, Aurora, CO, USA
| | - Elisabeth F Callen
- American Academy of Family Physicians, Leawood, KS, USA
- DARTNet Institute, Aurora, CO, USA
| | - Tarin Clay
- American Academy of Family Physicians, Leawood, KS, USA
- DARTNet Institute, Aurora, CO, USA
| | - David W Goodman
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA
- Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Lenard A Adler
- Departments of Psychiatry and Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, New York, USA
| | - Stephen V Faraone
- Departments of Psychiatry and Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA
| |
Collapse
|
2
|
Goetz CJ, Mushquash CJ, Maranzan KA. An Integrative Review of Barriers and Facilitators Associated With Mental Health Help Seeking Among Indigenous Populations. Psychiatr Serv 2023; 74:272-281. [PMID: 36065579 DOI: 10.1176/appi.ps.202100503] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
OBJECTIVE Indigenous populations, compared with majority populations, have a reduced likelihood of receiving professional help for mental health, contributing to health disparities. To increase use of and access to mental health services for Indigenous people, specific factors that affect service use need to be examined. An integrative review was undertaken of the barriers to and facilitators of help seeking and service use for Indigenous populations in Canada, the United States, Australia, and the Pacific Islands. METHODS Five databases-PsycINFO, PubMed, Web of Science, Social Services Abstracts, and Bibliography of Native North Americans-and gray literature were searched to identify original studies with data specific to Indigenous people. A qualitative analysis of common themes among the studies was conducted, along with a quality appraisal of included articles. Of the 1,010 records identified, the final synthesis included 41 articles. RESULTS Six main themes emerged: informal supports, which were often used as a first choice for help seeking compared with formal services; structural obstacles and supports; stigma and shame; self-reliance and uncertainty about services; cultural factors and mistrust of mainstream services; and the need for outreach and information regarding mental illness and services. CONCLUSIONS Policy implications include needed structural changes to decrease mistrust of mainstream systems and services and increased funding and resource availability. Along with technology-facilitated treatment, programs for Indigenous people, families, and communities that enhance education and foster positive relationships can serve as a first step toward Indigenous people becoming comfortable with the idea of talking about mental health and with seeking treatment.
Collapse
Affiliation(s)
- Christiana J Goetz
- Department of Psychology, Lakehead University, Thunder Bay, Ontario, Canada
| | | | - K Amanda Maranzan
- Department of Psychology, Lakehead University, Thunder Bay, Ontario, Canada
| |
Collapse
|
3
|
Crowe A, Averett P, Harris J’RA, Crumb L, Dietz SS. “The Problem Will Pass:” Attitudes of Latinx Adults Toward Mental Illness and Help Seeking. INTERNATIONAL JOURNAL FOR THE ADVANCEMENT OF COUNSELLING 2022. [DOI: 10.1007/s10447-021-09425-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Waldron IR. The wounds that do not heal: Black expendability and the traumatizing aftereffects of anti-Black police violence. EQUALITY, DIVERSITY AND INCLUSION: AN INTERNATIONAL JOURNAL 2020. [DOI: 10.1108/edi-06-2020-0175] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
PurposeThe murders of Black people at the hands of police in 2020 have led to global protests that have called on public officials to defund or abolish the police. What has been drowned out in these conversations, however, is the traumatizing aftereffects of anti-Black police violence as a public health crisis. In this paper, I argue that the racial terrorism of anti-Black police violence is a deeply felt wound in Black communities that extends beyond the individuals who directly experience it and that this type of collective trauma must be understood as an urgent public health crisis.Design/methodology/approachUsing published studies and online commentaries on anti-Black police violence and its mental health impacts in Canada and the United States, this paper examines the mental health impacts of anti-Black police violence at both the individual and community levels.FindingsA public health response to the traumatizing aftereffects of anti-Black police violence and other forms of state violence must highlight important policy imperatives, such as policies of action focused on improving the public health system. It must also encompass a recognition that the public health crisis of anti-Black police violence is not solvable solely by public health agencies alone. Rather, strategic opportunities to address this crisis arise at every level of governmental interaction, including law enforcement, health care, employment, business, education and the media.Originality/valueWhile the impact of anti-Black police violence on the mental health of Black individuals has been emerging in the literature over the last several years, what has been less focused on and what I address in this paper is how the threat of that violence lingers in Black communities long after the protestors have packed up their megaphones, resulting in collective trauma in Black communities.
Collapse
|
5
|
McGregor B, Li C, Baltrus P, Douglas M, Hopkins J, Wrenn G, Holden K, Respress E, Gaglioti A. Racial and Ethnic Disparities in Treatment and Treatment Type for Depression in a National Sample of Medicaid Recipients. Psychiatr Serv 2020; 71:663-669. [PMID: 32237981 PMCID: PMC8842821 DOI: 10.1176/appi.ps.201900407] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE The purpose of this secondary data analysis was to describe racial-ethnic disparities in receipt of depression treatment and treatment modality among adult Medicaid beneficiaries with depression from a nationally representative sample-28 states and the District of Columbia-of Medicaid beneficiaries (N=599,421). METHODS Medicaid claims data were extracted from the full 2008-2009 Medicaid Analytic Extract file. The primary outcome was type of depression treatment: medication only, therapy only, medication and therapy, and no treatment. The secondary outcome was treatment for depression (yes-no). Crude and adjusted odds ratios (AORs) were generated for univariate and multivariate models, respectively, and 95% confidence intervals of odds ratios and p values were calculated. RESULTS There were 599,421 individuals in the sample. Rates of depression treatment were lower for African Americans and Hispanics, compared with Caucasians. Percentages receiving no treatment were 19.9% of African Americans, 15.2% of Hispanics, and 11.9% of Caucasians. After full adjustment, African Americans were about half as likely as Caucasians to receive treatment (AOR=0.52), Hispanics were about a third as likely (AOR=0.71), and those from other racial-ethnic groups were about a fifth as likely (AOR=0.84). Caucasians were more likely than any other group to receive medication only. CONCLUSIONS This study contributes to evidence about the intersection of social factors and health outcomes and discusses health care engagement, stigma, and policy drivers of racial-ethnic disparities. The study is the first to identify disparities in rates and types of depression treatment among racial-ethnic subgroups of Medicaid beneficiaries in a nationally representative sample.
Collapse
Affiliation(s)
- Brian McGregor
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Chaohua Li
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Peter Baltrus
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Megan Douglas
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Jammie Hopkins
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Glenda Wrenn
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Kisha Holden
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Ebony Respress
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| | - Anne Gaglioti
- Department of Psychiatry and Behavioral Sciences (McGregor, Wrenn, Holden), Satcher Health Leadership Institute (McGregor, Douglas, Respress), National Center for Primary Care (Li, Baltrus, Douglas, Gaglioti), Department of Community Health and Preventive Medicine (Baltrus, Douglas, Hopkins), and Department of Family Medicine (Gaglioti), Morehouse School of Medicine, Atlanta
| |
Collapse
|
6
|
Variation of Behavioral Health Care by Behavioral Health Symptom Profile Among a Diverse Group of Pregnant and Parenting Mothers. J Behav Health Serv Res 2020; 48:36-49. [PMID: 32333363 DOI: 10.1007/s11414-020-09701-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
This study examines the association between behavioral health symptoms and use of behavioral health care (BHC; i.e., past year counseling and/or regular use of psychiatric medication) among a diverse group of mothers of toddlers. Data were from the Fragile Families and Child Wellbeing study (N = 4205 mothers). The association between symptom profiles (i.e., depressive, anxiety, and alcohol and drug dependence) and use of BHC was estimated with logistic regression models. Potential moderation by race/ethnicity was examined. Complex symptom profiles, older age, functional limitations, prior behavioral health symptoms, and having Medicaid were associated with increased BHC use. While BHC use varied by symptom profile (but not by race/ethnicity), BHC use was low across profiles. Pregnant women and women of color were most likely to have unmet needs, underscoring the need to improve screening and management systems for these populations.
Collapse
|
7
|
Cook BL, Hou SSY, Lee-Tauler SY, Progovac AM, Samson F, Sanchez MJ. A Review of Mental Health and Mental Health Care Disparities Research: 2011-2014. Med Care Res Rev 2019; 76:683-710. [PMID: 29877136 DOI: 10.1177/1077558718780592] [Citation(s) in RCA: 94] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2024]
Abstract
Racial/ethnic minorities in the United States are more likely than Whites to have severe and persistent mental disorders and less likely to access mental health care. This comprehensive review evaluates studies of mental health and mental health care disparities funded by the National Institute of Mental Health (NIMH) to provide a benchmark for the 2015 NIMH revised strategic plan. A total of 615 articles were categorized into five pathways underlying mental health care and three pathways underlying mental health disparities. Identified studies demonstrate that socioeconomic mechanisms and demographic moderators of disparities in mental health status and treatment are well described, as are treatment options that support diverse patient needs. In contrast, there is a need for studies that focus on community- and policy-level predictors of mental health care disparities, link discrimination- and trauma-induced neurobiological pathways to disparities in mental illness, assess the cost effectiveness of disparities reduction programs, and scale up culturally adapted interventions.
Collapse
Affiliation(s)
- Benjamin Lê Cook
- Cambridge Health Alliance, Cambridge, MA, USA
- Uniformed Services University of the Health Sciences, North Bethesda, MD, USA
| | | | - Su Yeon Lee-Tauler
- Uniformed Services University of the Health Sciences, North Bethesda, MD, USA
| | - Ana Maria Progovac
- Cambridge Health Alliance, Cambridge, MA, USA
- Uniformed Services University of the Health Sciences, North Bethesda, MD, USA
| | | | | |
Collapse
|
8
|
Barriers and Opportunities: Examining Attitudes Toward Traditional and Mobile Health Services in a Non-Clinical Sample of Non-Hispanic White and Latino/a Undergraduates. ACTA ACUST UNITED AC 2018. [DOI: 10.1007/s41347-018-0059-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
9
|
Factors Associated with American Indian Mental Health Service Use in Comparison with White Older Adults. J Racial Ethn Health Disparities 2017; 5:847-859. [PMID: 29052176 DOI: 10.1007/s40615-017-0430-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2017] [Revised: 09/05/2017] [Accepted: 09/07/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVE Our objective was to identify the factors that impact mental health service use among American Indian (AI) older adults living in South Dakota compared to their White counterparts. DESIGN AND METHODS Using a cross-sectional design with 735 participants (n = 502 Whites, n = 233 AIs), we used ordinal regressions to analyze the extent to which predisposing, need, and enabling/hindering factors predicted the level of mental health service utilization. RESULTS White older adults used more mental health services as compared with AI older adults. For both groups, more adverse childhood experiences along with prior negative experience with mental health service use were significantly related to an increased level of mental health service use. Compared to their White counterparts, AI older adults who reported a higher level of depressive symptoms, better self-perceived physical health, and a more positive attitude toward mental health services tended to use more mental health services. CONCLUSIONS To reduce mental health disparities among AI older adults, community, local government, and academic partners should pay attention to how to encourage the use of mental health services to meet the unique needs of AI older adults.
Collapse
|
10
|
Campbell-Sills L, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Stein MB. Improving outcomes for patients with medication-resistant anxiety: effects of collaborative care with cognitive behavioral therapy. Depress Anxiety 2016; 33:1099-1106. [PMID: 27775823 DOI: 10.1002/da.22574] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Revised: 08/29/2016] [Accepted: 09/11/2016] [Indexed: 12/28/2022] Open
Abstract
BACKGROUND Many patients with anxiety disorders remain symptomatic after receiving evidence-based treatment, yet research on treatment-resistant anxiety is limited. We evaluated effects of cognitive behavioral therapy (CBT) on outcomes of patients with medication-resistant anxiety disorders using data from the Coordinated Anxiety Learning and Management (CALM) trial. METHODS Primary care patients who met study entry criteria (including DSM-IV diagnosis of generalized anxiety disorder, panic disorder, posttraumatic stress disorder, or social anxiety disorder) despite ongoing pharmacotherapy of appropriate type, dose, and duration were classified as medication resistant (n = 227). Logistic regression was used to estimate effects of CALM's CBT program (CALM-CBT; chosen by 104 of 117 medication-resistant patients randomized to CALM) versus usual care (UC; n = 110) on response [≥ 50% reduction of 12-item Brief Symptom Inventory (BSI-12) anxiety and somatic symptom score] and remission (BSI-12 < 6) at 6, 12, and 18 months. Within-group analyses examined outcomes by treatment choice (CBT vs. CBT plus medication management) and CBT dose. RESULTS Approximately 58% of medication-resistant CALM-CBT patients responded and 46% remitted during the study. Relative to UC, CALM-CBT was associated with greater response at 6 months (AOR = 3.78, 95% CI 2.02-7.07) and 12 months (AOR = 2.49, 95% CI 1.36-4.58) and remission at 6, 12, and 18 months (AORs = 2.44 to 3.18). Patients in CBT plus medication management fared no better than those in CBT only. Some evidence suggested higher CBT dose produced better outcomes. CONCLUSIONS CBT can improve outcomes for patients whose anxiety symptoms are resistant to standard pharmacotherapy.
Collapse
Affiliation(s)
| | - Peter P Roy-Byrne
- Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA
| | - Michelle G Craske
- Department of Psychology, University of California, Los Angeles, CA, USA
| | - Alexander Bystritsky
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
| | - Greer Sullivan
- Department of Psychiatry, University of California Riverside School of Medicine, Riverside, CA, USA
| | - Murray B Stein
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.,VA San Diego Healthcare System, San Diego, CA, USA.,Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA
| |
Collapse
|
11
|
Lokko HN, Chen JA, Parekh RI, Stern TA. Racial and Ethnic Diversity in the US Psychiatric Workforce: A Perspective and Recommendations. ACADEMIC PSYCHIATRY : THE JOURNAL OF THE AMERICAN ASSOCIATION OF DIRECTORS OF PSYCHIATRIC RESIDENCY TRAINING AND THE ASSOCIATION FOR ACADEMIC PSYCHIATRY 2016; 40:898-904. [PMID: 27421839 DOI: 10.1007/s40596-016-0591-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/25/2016] [Accepted: 07/04/2016] [Indexed: 06/06/2023]
Affiliation(s)
- Hermioni N Lokko
- Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
| | - Justin A Chen
- Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
| | | | - Theodore A Stern
- Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
| |
Collapse
|
12
|
Coleman KJ, Stewart C, Waitzfelder BE, Zeber JE, Morales LS, Ahmed AT, Ahmedani BK, Beck A, Copeland LA, Cummings JR, Hunkeler EM, Lindberg NM, Lynch F, Lu CY, Owen-Smith AA, Trinacty CM, Whitebird RR, Simon GE. Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv 2016; 67:749-57. [PMID: 27079987 PMCID: PMC4930394 DOI: 10.1176/appi.ps.201500217] [Citation(s) in RCA: 84] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVE The objective of this study was to characterize racial-ethnic variation in diagnoses and treatment of mental disorders in large not-for-profit health care systems. METHODS Participating systems were 11 private, not-for-profit health care organizations constituting the Mental Health Research Network, with a combined 7,523,956 patients age 18 or older who received care during 2011. Rates of diagnoses, prescription of psychotropic medications, and total formal psychotherapy sessions received were obtained from insurance claims and electronic medical record databases across all health care settings. RESULTS Of the 7.5 million patients in the study, 1.2 million (15.6%) received a psychiatric diagnosis in 2011. This varied significantly by race-ethnicity, with Native American/Alaskan Native patients having the highest rates of any diagnosis (20.6%) and Asians having the lowest rates (7.5%). Among patients with a psychiatric diagnosis, 73% (N=850,585) received a psychotropic medication. Non-Hispanic white patients were significantly more likely (77.8%) than other racial-ethnic groups (odds ratio [OR] range .48-.81) to receive medication. In contrast, only 34% of patients with a psychiatric diagnosis (N=548,837) received formal psychotherapy. Racial-ethnic differences were most pronounced for depression and schizophrenia; compared with whites, non-Hispanic blacks were more likely to receive formal psychotherapy for their depression (OR=1.20) or for their schizophrenia (OR=2.64). CONCLUSIONS There were significant racial-ethnic differences in diagnosis and treatment of psychiatric conditions across 11 U.S. health care systems. Further study is needed to understand underlying causes of these observed differences and whether processes and outcomes of care are equitable across these diverse patient populations.
Collapse
Affiliation(s)
- Karen J Coleman
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Christine Stewart
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Beth E Waitzfelder
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - John E Zeber
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Leo S Morales
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Ameena T Ahmed
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Brian K Ahmedani
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Arne Beck
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Laurel A Copeland
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Janet R Cummings
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Enid M Hunkeler
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Nangel M Lindberg
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Frances Lynch
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Christine Y Lu
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Ashli A Owen-Smith
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Connie Mah Trinacty
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Robin R Whitebird
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| | - Gregory E Simon
- Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (e-mail: ). Dr. Stewart and Dr. Simon are with the Group Health Research Institute, Group Health Cooperative, Seattle. Dr. Waitzfelder and Dr. Trinacty are with the Center for Health Research, Kaiser Permanente Hawaii, Honolulu. Dr. Zeber and Dr. Copeland are with Health Services Research and Development, U.S. Department of Veterans Affairs, Temple, Texas, and the Center for Applied Health Research, Baylor Scott and White Health, Temple, Texas. Dr. Morales is with the Center for Health Equity, Diversity and Inclusion, University of Washington, Seattle. Dr. Ahmed is with Kaiser Permanente Northern California, Permanente Medical Group, San Francisco. Dr. Ahmedani is with the Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit. Dr. Beck is with the Institute for Health Research, Kaiser Permanente Colorado, Denver. Dr. Cummings is with the Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta. Ms. Hunkeler is with the Division of Research, Kaiser Permanente Northern California, Oakland. Dr. Lindberg and Dr. Lynch are with the Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. Dr. Lu is with Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston. Dr. Owen-Smith is with the School of Public Health, Georgia State University, Atlanta. Dr. Whitebird is with the School of Social Work, University of St. Thomas/St. Catherine University, St. Paul, Minnesota
| |
Collapse
|
13
|
Illness perception, help-seeking attitudes, and knowledge related to obsessive-compulsive disorder across different ethnic groups: a community survey. Soc Psychiatry Psychiatr Epidemiol 2016; 51:455-64. [PMID: 26498926 DOI: 10.1007/s00127-015-1144-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2015] [Accepted: 10/13/2015] [Indexed: 10/22/2022]
Abstract
PURPOSE Despite similar prevalence rates across ethnicities, ethnic minorities with obsessive-compulsive disorder (OCD) are under-represented in research and clinical settings. The reasons for this disproportion have been sparsely studied. We explored potential differences in illness perception, help-seeking attitudes, illness knowledge, and causal attributions that could help explain the lower uptake of treatment for OCD amongst ethnic minorities. METHODS Two-hundred and ninety-three parents (139 White British, 61 Black African, 46 Black Caribbean, and 47 Indian) were recruited from the general population in South-East London, UK. Using a text vignette methodology, participants completed a survey including questions on illness perception, help-seeking attitudes, OCD knowledge, and causal attributions. RESULTS The groups did not differ in socio-demographic characteristics and family history of OCD. White British parents perceived that the OCD difficulties would have more negative impact on their children and that treatment would be more helpful, compared to the ethnic minorities; the largest differences were observed between White British and Indian parents. Ethnic minorities were more prone to say that would seek help from their religious communities. Black African parents were more in favor of not seeking help for the described difficulties and, in general, perceived more treatment barriers. White British parents seemed to be better informed about OCD than ethnic minority parents. CONCLUSIONS The results offer some plausible explanations for the large inequalities in access to services amongst ethnic minorities with OCD. Clinicians and policy-makers need to be aware of these socio-cultural factors when designing strategies to encourage help-seeking behaviors in these populations.
Collapse
|
14
|
Fernández de la Cruz L, Llorens M, Jassi A, Krebs G, Vidal-Ribas P, Radua J, Hatch SL, Bhugra D, Heyman I, Clark B, Mataix-Cols D. Ethnic inequalities in the use of secondary and tertiary mental health services among patients with obsessive-compulsive disorder. Br J Psychiatry 2015. [PMID: 26206866 DOI: 10.1192/bjp.bp.114.154062] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
BACKGROUND Obsessive-compulsive disorder (OCD) has similar prevalence rates across ethnic groups. However, ethnic minorities are underrepresented in clinical trials of OCD. It is unclear whether this is also the case in clinical services. AIMS To explore whether ethnic minorities with OCD are underrepresented in secondary and tertiary mental health services in the South London and Maudsley (SLaM) NHS Foundation Trust. METHOD The ethnic distribution of patients with OCD seen between 1999 and 2013 in SLaM (n = 1528) was compared with that of the general population in the catchment area using census data. A cohort of patients with depression (n = 22 716) was used for comparative purposes. RESULTS Ethnic minorities with OCD were severely underrepresented across services (-57%, 95% CI -62% to -52%). The magnitude of the observed inequalities was significantly more pronounced than in depression (-29%, 95% CI -31% to -27%). CONCLUSIONS There is a clear need to understand the reasons behind such ethnic inequalities and implement measures to reduce them.
Collapse
Affiliation(s)
- Lorena Fernández de la Cruz
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Marta Llorens
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Amita Jassi
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Georgina Krebs
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Pablo Vidal-Ribas
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Joaquim Radua
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Stephani L Hatch
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Dinesh Bhugra
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Isobel Heyman
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - Bruce Clark
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| | - David Mataix-Cols
- Lorena Fernández de la Cruz, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Marta Llorens, MD, King's College London, Institute of Psychiatry, London, UK; Amita Jassi, DClinPsy, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Georgina Krebs, DClinPsy, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London and National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; Pablo Vidal-Ribas, MSc, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Joaquim Radua, MD, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, Fundació per a la Investigació i la Docència Maria Angustias Giménez Research Unit, Germanes Hospitalàries, Barcelona and Centro de Investigación Biomédica en Red de Salud Mental, Barcelona, Spain; Stephani L. Hatch, PhD, Dinesh Bhugra, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK; Isobel Heyman, MBBS, PhD, FRCPsych, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, UK, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London and Great Ormond Street Hospital for Children, London, UK; Bruce Clark, MD, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK; David Mataix-Cols, PhD, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London, National and Specialist OCD Clinic for Young People, South London and Maudsley NHS Foundation Trust, London, UK and Department of Clinical Neu
| |
Collapse
|
15
|
Abstract
Despite strong efforts, the diagnosis and treatment of depression bring many challenges in the primary care setting. Screening for depression has been shown to be effective only if reliable systems of care are in place to ensure appropriate treatment by clinicians and adherence by patients. New evidence-based models of care for depression exist, but spread has been slow because of inadequate funding structures and conflicts within current clinical culture. The Affordable Care Act introduces potential opportunities to reorganize funding structures, conceivably leading to increased adoption of these collaborative care models. Suicide screening remains controversial.
Collapse
Affiliation(s)
- D Edward Deneke
- Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA.
| | - Heather E Schultz
- Inpatient Psychiatry, University of Michigan Hospital and Health Systems, University of Michigan University Hospital, 9C 9150, 1500 East Medical Center Drive, SPC 5120, Ann Arbor MI 48109, USA
| | - Thomas E Fluent
- Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA
| |
Collapse
|
16
|
Abstract
Despite strong efforts, the diagnosis and treatment of depression bring many challenges in the primary care setting. Screening for depression has been shown to be effective only if reliable systems of care are in place to ensure appropriate treatment by clinicians and adherence by patients. New evidence-based models of care for depression exist, but spread has been slow because of inadequate funding structures and conflicts within current clinical culture. The Affordable Care Act introduces potential opportunities to reorganize funding structures, conceivably leading to increased adoption of these collaborative care models. Suicide screening remains controversial.
Collapse
Affiliation(s)
- D Edward Deneke
- Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA.
| | - Heather Schultz
- Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA
| | - Thomas E Fluent
- Department of Psychiatry, University of Michigan Health System, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI 48109-2700, USA
| |
Collapse
|